Glycogenosis type II (GSDII) is an autosomal recessive lysosomal disease caused by a deficiency of alpha-glucosidase. The discovery of the acid alpha-glucosidase gene (GAA) has lead to rapid progress in understanding the molecular basis of GSD II. Three forms of the disease have been described: infantile GSDII results from complete alpha-glucosidase deficiency (Pompe disease), with hypotonia, cardiomegaly; the juvenile form is characterized by onset in the first decade, and cardiac involvement is absent or mild; the adult form of the disease has onset in the 3rd - 6th decade, about 30% of patients present respiratory insufficiency.
MP 5.06 Protocol for enzyme replacement therapy in late-onset glycogenosis type II (GSDII)
ANGELINI, CORRADO;SEMPLICINI, CLAUDIO
2007
Abstract
Glycogenosis type II (GSDII) is an autosomal recessive lysosomal disease caused by a deficiency of alpha-glucosidase. The discovery of the acid alpha-glucosidase gene (GAA) has lead to rapid progress in understanding the molecular basis of GSD II. Three forms of the disease have been described: infantile GSDII results from complete alpha-glucosidase deficiency (Pompe disease), with hypotonia, cardiomegaly; the juvenile form is characterized by onset in the first decade, and cardiac involvement is absent or mild; the adult form of the disease has onset in the 3rd - 6th decade, about 30% of patients present respiratory insufficiency.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.